CAMP4 Therapeutics Corporation (CAMP) |
| 6.02 -0.04 (-0.66%) 01-14 12:01 |
| Open: | 6.07 |
| High: | 6.12 |
| Low: | 5.9269 |
| Volume: | 18,276 |
| Market Cap: | 128(M) |
| PE Ratio: | -0.55 |
| Exchange: | NASDAQ |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 8.53 |
| Resistance 1: | 7.30 |
| Pivot price: | 6.01 |
| Support 1: | 4.91 |
| Support 2: | 3.43 |
| 52w High: | 7.305 |
| 52w Low: | 1.305 |
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Financials
| EPS | -51630000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 655.0 |
| Return on Equity (ttm) | -61.8 |
Company news
Tue, 13 Jan 2026
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why - Yahoo Finance
Fri, 09 Jan 2026
CAMP4 Therapeutics updates corporate investor presentation materials - TipRanks
Fri, 19 Dec 2025
Camp4 Therapeutics shares slide after $30 million equity offering priced - MSN
Fri, 19 Dec 2025
CAMP4 Therapeutics Announces $28 Million Common Stock Offering - The Globe and Mail
Thu, 18 Dec 2025
8-Day Rally Sends Camp4 Therapeutics Stock Up 119% - Trefis
Thu, 18 Dec 2025
CAMP4 Therapeutics prices $30 million common stock offering - Investing.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
